Viome Life Sciences, a Bellevue, WA-based longevity and preventative healthcare company, raised $86.5M in Series C funding.
The round, which brought the total amount to $175M, saw participation from Khosla Ventures, Bold Capital, WRG Ventures, and others.
The company intends to use the funds for research and development and retail expansion efforts.
Led by Founder and CEO Naveen Jain, Viome leverages AI and algorithms to analyze gene expression data from over 600,000 samples to provide at-home tests and custom-made health products. This includes a supplement formula made unique to every single individual as well as a personalized biotic blend for gut health and personalized oral biotic lozenges, for oral microbiome health.
FinSMEs
20/08/2023